Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-19, Stock:JNJ, The news for the past five days is as follows:
2021-04-12: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: ‘Unvaccinated folks’ are driving coronavirus surges as American society slowly reopens.NEWS3: I’d still trust vaccines to suppress emergence of more variants: Doctor.NEWS4: UPDATE 1-Spain to vaccinate 70-79 year olds with J&J's one-dose COVID-19 shot.NEWS5: Greece to receive first 33,600 doses of J&J COVID-19 vaccine this week.NEWS6: Pulmatrix Stock Is Trading Lower After JNJ's Lung Cancer Initiative Terminates PUR1800 Licensing Pact.NEWS7: Doctor on vaccine push: 'These vaccines work extremely well and that’s something to celebrate'.NEWS8: Spain to vaccinate 70-79 year olds with J&J's COVID-19 shot.NEWS9: REFILE-UPDATE 1-J&J begins COVID-19 vaccine supplies to EU, 50 mln doses expected in Q2 -lawmaker.NEWS10: J&J begins COVID-19 vaccine supplies to EU, 50 mln doses expected in Q2 -lawmaker.
2021-04-13: NEWS1: J&J Blood-Clot Pause Done to Educate Doctors, Monitor Cases.NEWS2: Flying, pregnancy, or taking the pill all carry much higher blood clot risks than the J&J vaccine.NEWS3: S&P 500 Hits Another New All-Time High.NEWS4: The Dow Fell 68 Points, but Tesla Stock Helped Lift the S&P 500 to a Record.NEWS5: Johnson & Johnson Vaccine Pause: What to Know If You Got or Scheduled the Shot.NEWS6: More likely to be struck by lightning? Americans weigh risk of J&J vaccine.NEWS7: Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says.NEWS8: RPT-U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots.NEWS9: Johnson & Johnson vaccine pause won’t hurt shot momentum, McConnell hopes.NEWS10: S&P 500 ends at record as stocks shake off JNJ vaccine pause and bond-yield slide.NEWS11: 5 at 5: Your Daily Digest for Real Estate Investing, 4/13/21.NEWS12: Moderna says that it COVID-19 vaccine continues to show 'strong efficacy'.NEWS13: Oil Rises With OPEC Expecting Demand Rebound to Absorb Output.NEWS14: Only one county left in purple tier as California's COVID-19 reopenings continue.NEWS15: Pfizer ramps up COVID-19 vaccine production for the U.S., CEO says.NEWS16: U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots.NEWS17: Canadian dollar recovers from 6-day low as greenback slides.NEWS18: CANADA FX DEBT-Canadian dollar recovers from 6-day low as greenback slides.NEWS19: Dow Jones Closes Near Session High Despite J&J News; Bitcoin Soars.NEWS20: J&J Stock Dives As FDA Halts Covid Vaccine Use On Blood-Clotting Issue.NEWS21: S&P 500 books record high and Nasdaq rallies 1.1% as stock market reacts to Johnson & Johnson pause, hot CPI report.NEWS22: J&J debt trades lower after pause of one-shot COVID-19 vaccine.NEWS23: Why Emergent BioSolutions Stock Fell Today.NEWS24: Nasdaq tops 14,000 while Dow comes off lows as bond yields slide.NEWS25: Biden says U.S. has enough vaccines for 'every single' American.NEWS26: Why Airline Shares Are Down Today.NEWS27: Johnson & Johnson vaccine pause: What to know if you got or scheduled the shot.NEWS28: Why Bad COVID-19 News Didn't Stop the Nasdaq From Rising Tuesday.NEWS29: Why Zoom Video Stock Jumped Today.NEWS30: Why Okta Stock Is Rising Today.NEWS31: CDC committee to hold emergency meeting for J&J's COVID-19 shot on Wednesday afternoon.NEWS32: Doctor on J&J vaccine pause: CDC is letting the public know they are taking any side effect seriously.NEWS33: Dow under pressure, Nasdaq climbs as U.S. pauses Johnson & Johnson COVID vaccine rollout.NEWS34: Dow Jones Falls 180 Points, But Apple Stock Jumps; Bitcoin Surges 5% As GBTC Gives Buy Signal.NEWS35: UPDATE 2-South Africa suspends J&J vaccine rollout after U.S. pause.NEWS36: UPDATE 1-U.S. has more than enough vaccine to maintain pace of inoculations as  J&J shot paused.NEWS37: Dow Jones Lags As 'Inflation Domino' Falls; J&J Dips On Covid Vaccine News; Nvidia Passes Buy.NEWS38: Stay-at-home ETFs benefit from J&J vaccine pause.NEWS39: Could the Johnson & Johnson Vaccine Pause Hurt Real Estate Investors?.NEWS40: Italy health min says thinks J&J vaccine will have to be used -agency.NEWS41: Airline stocks stumble after vaccine rollout snag.NEWS42: Johnson & Johnson vaccine setback sends shares of stay-at-home stocks like Zoom higher.NEWS43: EU Governments to Seek Deal on Controversial Covid Passports.NEWS44: We’re not seeing anything that is outside the bounds of what we typically see with new vaccines: Dr. Howard Forman .NEWS45: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS46: Dow Jones Lags As Inflation Rises; J&J Falls On Covid Vaccine News; Nvidia Passes Buy Point.NEWS47: Why Peloton, Teladoc, DocuSign, and Other Stay-at-Home Stocks Are Rising Today.NEWS48: The Johnson & Johnson COVID Vaccine Halt: Here's What Investors Need to Know.NEWS49: Dow Jones Slides, Tech Stocks Rally As FDA Calls For Pause On J&J Covid Vaccine; Bitcoin Surges To Record Highs.NEWS50: Stocks trade mixed, Dow under pressure as U.S. pauses Johnson & Johnson COVID vaccine rollout.NEWS51: Consumer Prices in U.S. Advance by Most in Nearly Nine Years.NEWS52: The J&J Vaccine Just Got Paused. ‘These Adverse Events Appear to Be Extremely Rare.’.NEWS53: Doctor on J&J vaccine: 'We’re talking about one in a million for these clots'.NEWS54: UPDATE 2-EU seeking clarification from J&J after rollout delay news - source.NEWS55: UPDATE 1-EXPLAINER-How worried should we be about blood clots linked to AstraZeneca and J&J vaccines?.NEWS56: Johnson & Johnson pause ‘will not have a significant impact on our vaccination plan,’ White House says.NEWS57: U.S. Gives Johnson & Johnson's COVID-19 Vaccine a Timeout.NEWS58: EU seeking clarification from J&J after rollout delay news - source.NEWS59: U.S. COVID vaccine program faces setback with J&J jab, as experts say there is no cause for alarm.NEWS60: Why Novavax and BioNTech Stocks Are Jumping Today.NEWS61: U.S. recommends pausing use of J&J’s COVID-19 vaccine after reports of rare blood clots.NEWS62: How COVID-19 transformed the biotech industry.NEWS63: U.S. pauses J&J COVID-19 vaccine over rare blood clots.NEWS64: Vaccine expert: The US doesn't need to rely on J&J vaccine.NEWS65: Consumer Price Index Rise 0.6%.NEWS66: UPDATE 1-Spain unaware of any delays in J&J COVID vaccine deliveries.NEWS67: Why American Airlines Stock Is Falling Today.NEWS68: EXPLAINER-How worried should we be about blood clots linked to AstraZeneca and J&J vaccines?.NEWS69: Moderna, BioNTech stocks surge after regulators halt use of J&J vaccine.NEWS70: Dow Jones Lags, Nasdaq Rallies As J&J Vaccine Paused; Bitcoin Spikes To New High, Nvidia Breaks Out.NEWS71: White House adviser says J&J pause to have little impact on U.S. vaccination plan.NEWS72: J&J says delaying rollout of COVID-19 vaccine in Europe.NEWS73: Tech shares rise but Dow under pressure as U.S. pauses Johnson & Johnson COVID vaccine rollout.NEWS74: Stock market reaction to J&J vaccine pause is ‘pretty modest’: economist.NEWS75: Moderna Rises, Johnson & Johnson Falls After Its Vaccine Pause Dents Stocks.NEWS76: Stocks wobble at Tuesday's open in face of vaccine pause, hot inflation print.NEWS77: FDA, CDC recommend pause in Johnson & Johnson COVID-19 vaccine.NEWS78: AstraZeneca (AZN) Farxiga COVID-19 Study Fails to Meet Goal.NEWS79: Belgium to continue with Johnson & Johnson vaccine for the time being.NEWS80: US STOCKS-S&P 500 set for muted open on strong inflation.NEWS81: UPDATE 1-Impact of J&J COVID-19 vaccine pause on U.S. reopening unclear -White House adviser.NEWS82: Benefits of J&J COVID-19 vaccine outweigh possible risks - Dutch drug regulator.NEWS83: UPDATE 1-Sweden to rule on use of Johnson & Johnson COVID-19 vaccine in coming days.NEWS84: Johnson & Johnson stock drop would shave about 25 points off the Dow's price.NEWS85: Here's a Multibillion-Dollar Market for Johnson & Johnson.NEWS86: India wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - government official.NEWS87: Johnson & Johnson Vaccine Paused on Blood Clot Concerns. What to Know..NEWS88: Stock Market Drops as U.S. Recommends Pause in Use of J&J Vaccine.NEWS89: Dow futures turn lower after U.S. agencies call for pause of Johnson & Johnson COVID vaccine.NEWS90: U.S. pauses use of J&J’s COVID-19 vaccine after reports of rare blood clots.NEWS91: Is J&J Stock A Buy As Blood-Clot Question Clouds Its European Future?.NEWS92: Dow futures turn south Tuesday after FDA and CDC call for pause of Johnson & Johnson COVID vaccine.NEWS93: UPDATE: FDA and CDC call for pause in use of J&J vaccine over blood clotting disorder.NEWS94: UPDATE 1-U.S. to call for pause on Johnson & Johnson's COVID-19 vaccine - NYT.NEWS95: Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?.NEWS96: Premarket Movers Tuesday - J&J, Moderna, Nvidia.NEWS97: US CDC and FDA Pause Johnson & Johnson COVID Vaccine Use; Shares Slide.NEWS98: UPDATE 1-Australia reports second Astrazeneca blood clot case, vaccine rollout steady.NEWS99: Australia won’t be buying Johnson & Johnson COVID-19 vaccine.NEWS100: Australia shelves plans to buy J&J's one-dose COVID-19 vaccine.NEWS101: US health agencies call for pause of Johnson & Johnson vaccine rollout.
2021-04-14: NEWS1: CDC committee votes to extend the ‘pause’ for J&J’s COVID-19 shot.NEWS2: CDC Panel Talk Ends Without Vote; Pfizer Boost: Virus Update.NEWS3: What Does The J&J Covid Vaccine Debacle Mean For Herd Immunity?.NEWS4: Stocks Mixed as Wall Street Banks Kick Off Earnings Season.NEWS5: Denmark Is First Country to Permanently Stop Use of AstraZeneca Vaccine.NEWS6: Venezuela's seeking of specific vaccines will slow inoculation, Guaido says.NEWS7: 'The abundance of caution is good,' it gives clinicians time to figure out if the complications are due to the vaccine: Doctor.NEWS8: Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals: sources.NEWS9: Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals -sources.NEWS10: Pfizer to Raise EU Vaccine Supply by 25%.NEWS11: Johnson & Johnson’s Vaccine Pain Could Be Moderna’s and Pfizer’s Vaccine Gain.NEWS12: Vaccine transparency is ‘the best course of action’: Doctor .NEWS13: ‘It was a wise decision to spread the risk’: Johnson & Johnson saga reveals vulnerabilities in COVID-19 vaccine strategy.NEWS14: U.S. in unique position to force increased accountability at the WHO: FDD.NEWS15: Belgium delays start of Johnson & Johnson vaccination.NEWS16: Moderna CEO sees likely need for COVID booster for high-risk groups, eyes flu market.NEWS17: Coronavirus J&J vaccine concerns 'are very, very tiny risks worth taking': Doctor.NEWS18: UPDATE 1-Fauci says pause on J&J COVID-19 shot should not prompt vaccine hesitancy.NEWS19: Why Novavax Stock Is Jumping Again Today.NEWS20: Michigan Doctor on case spike: 'Michigan has the highest percent of variants'.NEWS21: Why Fastly Stock Popped This Morning.NEWS22: REFILE-Fauci says U.S pause on J&J COVID-19 shot should not prompt vaccine hesitancy.NEWS23: Europe's vaccine rollout hit by doubts over J&J, AstraZeneca shots.NEWS24: UPDATE 2-ECB's Lagarde says euro zone economy still on crutches.NEWS25: JNJ Vaccine Pause Gives Stay-at-Home ETFs a Shot in the Arm.NEWS26: Moderna is committed to keep chasing new COVID variants: CEO.NEWS27: Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine.NEWS28: Pfizer Will Send More Vaccine Doses After J&J Pause.NEWS29: Italy suspends distribution of J&J shots after use paused in U.S..NEWS30: UPDATE 2-France to roll out J&J COVID-19 vaccine as planned, Spanish, Dutch wait.NEWS31: UPDATE 1-EU drug regulator to issue view on J&J vaccine next week.NEWS32: Oil Jumps With U.S. Supply Drop Adding to Brighter Demand View.NEWS33: France says to administer J&J COVID-19 vaccine as planned.NEWS34: Stocks Creep Higher as Wall Street Banks Kick Off Earnings Season.NEWS35: UPDATE 1-Sweden pauses plans for J&J COVID-19 vaccinations, awaits review.NEWS36: UPDATE 1-U.S. CDC to weigh rare clot risk with J&J's COVID-19 vaccine as use paused.NEWS37: UPDATE 2-South Africa says non-refundable downpayments among onerous vaccine terms.NEWS38: Denmark becomes first country to permanently stop use of AstraZeneca vaccine.NEWS39: Stocks Pause as Wall Street Banks Kick Off Earnings Season.NEWS40: Is J&J's COVID-19 Vaccine Setback a Boon for Other Players?.NEWS41: J&J investor calls on shareholders to reject CEO Gorsky's pay.NEWS42: S&P Reaches New Record Ahead of Big Bank Reports.NEWS43: UPDATE 1-Spain confident on vaccination targets despite J&J suspension.NEWS44: Stock Market News for Apr 14, 2021.NEWS45: J&J and AstraZeneca sagas reveal key strengths — and vulnerabilities — in COVID-19 mass-vaccination campaign.NEWS46: Johnson & Johnson saga reveals critical strengths — and weaknesses — in U.S. COVID-19 vaccination strategy.NEWS47: EU moves up delivery for 50 million BioNTech and Pfizer COVID-19 vaccine doses.NEWS48: It’s a Coinbase World. JPMorgan Is Just Living in It..NEWS49: Which Vaccine Maker Will Win the Fight Against COVID-19?.NEWS50: Dow Jones Futures: Tesla, Nvidia In Buy Zones; Bitcoin Soars As Coinbase IPO Looms; JPMorgan Earnings Top.NEWS51: Moderna Previews Its Pipeline of Vaccines. The Stock Is Rising..NEWS52: Global Stocks Trade Mixed as Wall Street Banks Kick Off Earnings Season.NEWS53: J&J (JNJ) COVID-19 Jab to be Paused on FDA/CDC Recommendation.NEWS54: Denmark to halt use of AstraZeneca vaccine altogether: reports.NEWS55: UPDATE 2-EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper.NEWS56: Could Johnson & Johnson Be a Big Winner in the Flu Vaccine Market?.NEWS57: Global Stocks Inch Higher as Goldman Sachs and JPMorgan Get Ready to Kick Off Earnings Season.NEWS58: Johnson & Johnson's COVID Vaccine Paused: 5 Answers to Your Questions.NEWS59: European stocks struggle for traction. Shares of LVMH and SAP climb on results..NEWS60: Ireland considers extending gap between Pfizer vaccine doses.NEWS61: UPDATE 1-South Africa says downpayments to J&J, Pfizer not refundable.NEWS62: LVMH helps Paris stock market to new high as shares rally globally.NEWS63: EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper.NEWS64: Covid Test Maker Cue Health Taps Morgan Stanley, Goldman for IPO.NEWS65: Why Moderna Stock Surged Today.NEWS66: J&J vaccine pause threatens to dent public confidence, warn experts.
2021-04-15: NEWS1: ‘What determines when?’ Dr. Fauci outlines when COVID-19 will no longer be a ‘threat’.NEWS2: Mass vaccination was never expected to go perfectly — or provide 100% protection against COVID-19.NEWS3: Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?.NEWS4: How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And Others.NEWS5: Coronavirus update: J&J vaccine pause remains, Oxford studies blood clots and COVID-19 vaccines.NEWS6: More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President.NEWS7: FDA, CDC precaution with vaccine side effects is ‘encouraging’: Doctor.NEWS8: Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds.NEWS9: When COVID hit home for NYC’s health commissioner Dr. Dave Chokshi.NEWS10: Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine.NEWS11: Vaccination in the U.S. was never expected to go perfectly — or provide 100% protection against COVID-19.NEWS12: Dow ETF at All-Time Highs as Q1 Earnings Kick Off.NEWS13: J&J Vaccine Pause Could Boost Pfizer, Moderna Stock.NEWS14: Moderna (MRNA) Gives Pipeline Update, to Initiate New Pivotal Study.NEWS15: Poland starts J&J COVID-19 jabs, says benefits outweigh risks.NEWS16: UK scientists find higher risk of brain clots from COVID-19 compared with vaccines.NEWS17: SMART Global, General Motors, Moderna, BioNTech and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day.NEWS18: Inovio Is Still Working On A Midstage Covid Vaccine Test — Is It A Buy?.NEWS19: Will J&J (JNJ) Kickstart Pharma Q1 Earnings With a Beat?.NEWS20: UPDATE 1-Hungary in talks to plug expected shortfall in COVID-19 vaccine deliveries.NEWS21: Coronavirus tally: Global cases of COVID-19 top138 million and UI.S. death toll above 564,000.NEWS22: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.NEWS23: India vows to decide on foreign vaccines within 3 days to fast-track imports.NEWS24: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’.NEWS25: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign.NEWS26: Norway delays AstraZeneca vaccine ruling to further probe risks.
2021-04-16: NEWS1: UPDATE 1-J&J scientists refute idea that COVID-19 vaccine's design linked to clots.NEWS2: Stock Market Rally Keeps Rising As Treasury Yields Fall Despite Strong Earnings, Economic Data; Goldman, Nvidia, Coinbase In Focus.NEWS3: 'You can think of it like an annual flu shot': Doctor on possible COVID-19 booster shots.NEWS4: Why comparing blood clot risks from COVID-19 vaccines and birth control pills doesn’t work.NEWS5: The push to vaccinate farm workers against COVID-19.NEWS6: J&J scientists refute 'class effect' to blame for clots in those who got its COVID-19 vaccine.NEWS7: Vaccinating kids will be very important in getting to herd immunity: Expert.NEWS8: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings.NEWS9: Drug companies to face first opioid trial following pandemic delays.NEWS10: Doctor: COVID-19 vaccines 'do lead to a really strong immune response'.NEWS11: J&J’s Vaccine Pause Could Have Ripple Effects for the World.NEWS12: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%.NEWS13: UPDATE 2-J&J COVID-19 vaccine pause to be reviewed by U.S. panel next week.NEWS14: WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever.NEWS15: CDC committee to meet again on April 23 to discuss J&J's COVID-19 shot.NEWS16: Moderna, Pfizer Rebuffed J&J Proposal for Joint Vaccine Safety Exam, WSJ Reports.NEWS17: Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir.NEWS18: The J&J Vaccine Pause Should Worry Us All. What to Know..NEWS19: Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline.NEWS20: This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar.NEWS21: UPDATE 1-Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks - WSJ.NEWS22: Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout.NEWS23: Will Solid Pharma Unit Performance Drive J&J (JNJ) Q1 Earnings?.NEWS24: Pfizer, Moderna Reportedly Decline J&J Request to Study Clot Risk.

Answer: Rise